Klotho restoration via ACE2 activation: A potential therapeutic strategy against acute kidney injury-diabetes comorbidity
- 28 August 2022
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1868 (12) , 166532
Abstract
No abstract availableKeywords
Funding Information
- Anusandhan National Research Foundation (EEQ/2019/000308)
This publication has 39 references indexed in Scilit:
- Klotho restoration via acetylation of Peroxisome Proliferation–Activated Receptor γ reduces the progression of chronic kidney diseaseKidney International, 2017
- Diminazene aceturate prevents nephropathy by increasing glomerular ACE2 and AT2 receptor expression in a rat model of type1 diabetesBritish Journal of Pharmacology, 2017
- Recombinant α-Klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathyKidney International, 2017
- TRIP13-deficient tubular epithelial cells are susceptible to apoptosis following acute kidney injuryScientific Reports, 2017
- Angiotensin converting enzyme versus angiotensin converting enzyme-2 selectivity of MLN-4760 and DX600 in human and murine bone marrow-derived cellsEuropean Journal of Pharmacology, 2016
- Klotho Prevents Translocation of NFκB2016
- Inhibition of H3K9 histone methyltransferase G9a attenuates renal fibrosis and retains klotho expressionKidney International, 2016
- Short-Term Treatment with Diminazene Aceturate Ameliorates the Reduction in Kidney ACE2 Activity in Rats with Subtotal NephrectomyPLOS ONE, 2015
- Renal Klotho expression in patients with acute kidney injury is associated with the severity of the injuryThe Korean Journal of Internal Medicine, 2015
- Loss of ACE2 Exacerbates Murine Renal Ischemia-Reperfusion InjuryPLOS ONE, 2013